(Q48186630)

9 February 2018

title

T2 lesions and rate of progression of disability in multiple sclerosis. (English)

1 reference

9 February 2018

0 references

6

1 reference

9 February 2018

author name string

J P Mostert

1

1 reference

9 February 2018

M W Koch

2

1 reference

9 February 2018

C Steen

3

1 reference

9 February 2018

D J Heersema

4

1 reference

9 February 2018

J C De Groot

5

1 reference

9 February 2018

publication date

1 December 2010

1 reference

9 February 2018

European Journal of Neurology

published in

1 reference

9 February 2018

volume

17

1 reference

9 February 2018

issue

12

1 reference

9 February 2018

page(s)

1471-1475

1 reference

9 February 2018

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

1 reference

Benign course in multiple sclerosis: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Role of MRI in multiple sclerosis I: inflammation and lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Secondary progressive multiple sclerosis: current knowledge and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

The contribution of demyelination to axonal loss in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Predictive value of MRI findings in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03093.X

10.1111/J.1468-1331.2010.03093.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

release_njsycawowza5zks6g7z6dqtzau

Fatcat ID

0 references

1 reference

9 February 2018